Featured Research

from universities, journals, and other organizations

Jury’s Still Out On Use Of Marijuana Derivative For Multiple Sclerosis

Date:
May 16, 2002
Source:
American Academy Of Neurology
Summary:
Anecdotal claims of the benefits of marijuana for people with multiple sclerosis (MS) have been around for years, but the few studies on the topic have been small and inconclusive. A new study suggests that marijuana derivatives do not improve MS symptoms, but researchers say more studies need to be done before conclusions can be reached.

St. Paul, MN – Anecdotal claims of the benefits of marijuana for people with multiple sclerosis (MS) have been around for years, but the few studies on the topic have been small and inconclusive. A new study suggests that marijuana derivatives do not improve MS symptoms, but researchers say more studies need to be done before conclusions can be reached.

At 16 patients, the study is the largest randomized, controlled clinical trial on this topic. The study is published in the May 14 issue of Neurology, the scientific journal of the American Academy of Neurology. The patients were given capsules of a placebo, marijuana plant-extract, or synthetic tetrahydrocannabinol (THC), which is the active ingredient in marijuana, for four weeks each.

The patients had severe spasticity, the MS symptom that some reports have found the most responsive to marijuana treatment. Spasticity, one of the more common symptoms of MS, involves involuntary muscle stiffness and/or spasms.

The study found that both the synthetic THC and the plant-extract were safe for patients, although side effects such as dizziness and headache were more common with plant-extract treatment. The study was designed to determine whether the marijuana derivatives are safe for patients. It was not designed to determine how effective they are in treating MS symptoms.

“Due to the limited numbers of patients, we can’t draw any definite conclusions,” said study author Joep Killestein, MD, of the VU Medical Center in Amsterdam, Netherlands. “But these results suggest that synthetic THC and plant-extract do not improve symptoms for MS patients.”

There were no differences in the patients’ level of spasticity while taking placebo and either of the marijuana derivatives, according to neurologist Chris H. Polman, who supervised the study. Patients’ muscle tone improved while on the drug treatments, but their ratings on a scale measuring overall disability declined. In their own rating of their symptoms, patients said they did worse while using the drugs than when on the placebo.

The researchers noted a couple possible reasons why no benefit was found from using the marijuana derivatives.

“One could be the way the drug was given – in a capsule,” Killestein said. “THC is reasonably absorbed by the stomach, but the process is slow and it is absorbed faster in some people than in others.” Another possible explanation is that the dose used was too low to show a benefit, Killestein said. “But with the number of side effects patients experienced, especially with the plant-extract, we wouldn’t recommend using a higher dosage,” he said.

The study was financially supported by the Dutch Ministry of Health, Welfare and Sport. In an editorial accompanying the article, neurologist Alan J. Thompson, MD, of Institute of Neurology at University College London in England, noted that a study of 660 patients receiving plant-extract, THC and placebo is underway in the United Kingdom.

“Right now, fundamental questions about the potential value of cannabis (marijuana) remain unanswered,” Thompson said. “Hopefully they will be adequately addressed in the U.K. study.”

The American Academy of Neurology, an association of more than 18,000 neurologists and neuroscience professionals, is dedicated to improving patient care through education and research. For more information about the American Academy of Neurology, visit its web site at http://www.aan.com.


Story Source:

The above story is based on materials provided by American Academy Of Neurology. Note: Materials may be edited for content and length.


Cite This Page:

American Academy Of Neurology. "Jury’s Still Out On Use Of Marijuana Derivative For Multiple Sclerosis." ScienceDaily. ScienceDaily, 16 May 2002. <www.sciencedaily.com/releases/2002/05/020514075629.htm>.
American Academy Of Neurology. (2002, May 16). Jury’s Still Out On Use Of Marijuana Derivative For Multiple Sclerosis. ScienceDaily. Retrieved September 15, 2014 from www.sciencedaily.com/releases/2002/05/020514075629.htm
American Academy Of Neurology. "Jury’s Still Out On Use Of Marijuana Derivative For Multiple Sclerosis." ScienceDaily. www.sciencedaily.com/releases/2002/05/020514075629.htm (accessed September 15, 2014).

Share This



More Mind & Brain News

Monday, September 15, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Shocker: Journalists Are Utterly Addicted To Coffee

Shocker: Journalists Are Utterly Addicted To Coffee

Newsy (Sep. 13, 2014) A U.K. survey found that journalists consumed the most amount of coffee, but that's only the tip of the coffee-related statistics iceberg. Video provided by Newsy
Powered by NewsLook.com
'Magic Mushrooms' Could Help Smokers Quit

'Magic Mushrooms' Could Help Smokers Quit

Newsy (Sep. 11, 2014) In a small study, researchers found that the majority of long-time smokers quit after taking psilocybin pills and undergoing therapy sessions. Video provided by Newsy
Powered by NewsLook.com
'Fat Shaming' Might Actually Cause Weight Gain

'Fat Shaming' Might Actually Cause Weight Gain

Newsy (Sep. 11, 2014) A study for University College London suggests obese people who are discriminated against gain more weight than those who are not. Video provided by Newsy
Powered by NewsLook.com
Common Sleeping, Anxiety Pills Linked To Alzheimer's

Common Sleeping, Anxiety Pills Linked To Alzheimer's

Newsy (Sep. 10, 2014) Researchers found commonly prescribed sleeping and anxiety pills such as Xanax and Valium could lead to an increased risk for Alzheimer's disease. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

    Technology News



    Save/Print:
    Share:

    Free Subscriptions


    Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

    Get Social & Mobile


    Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

    Have Feedback?


    Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
    Mobile: iPhone Android Web
    Follow: Facebook Twitter Google+
    Subscribe: RSS Feeds Email Newsletters
    Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins